View in EDS HTML Full Text PDF Full Text

Global real-world experiences with pembrolizumab in advanced urothelial carcinoma after platinum-based chemotherapy: the ARON-2 study.

Saved in:
Bibliographic Details
Title: Global real-world experiences with pembrolizumab in advanced urothelial carcinoma after platinum-based chemotherapy: the ARON-2 study.
Authors: Massari F; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy. francesco.massari@aosp.bo.it., Santoni M; Oncology Unit, Macerata Hospital, via Santa Lucia 2, 62100, Macerata, Italy., Takeshita H; Department of Urology, Saitama Medical Center, Saitama Medical University, Saitama, Japan., Okada Y; Department of Urology, Saitama Medical Center, Saitama Medical University, Saitama, Japan., Tapia JC; Department of Medical Oncology, Institut d'Investigació Biomèdica Sant Pau, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain., Basso U; Medical Oncology 1 Unit, Department of Oncology, Istituto Oncologico Veneto IOV IRCCS, 35128, Padova, Italy., Maruzzo M; Medical Oncology 1 Unit, Department of Oncology, Istituto Oncologico Veneto IOV IRCCS, 35128, Padova, Italy., Scagliarini S; UOC di Oncologia, Azienda Ospedaliera di Rilievo Nazionale Cardarelli di Napoli, Naples, Italy., Büttner T; Department of Urology, University Hospital Bonn (UKB), 53127, Bonn, Germany., Fornarini G; IRCCS Ospedale Policlinico San Martino, Genoa, Italy., Myint ZW; Markey Cancer Center, University of Kentucky, Lexington, KY, 40536-0293, USA., Galli L; Oncology Unit 2, University Hospital of Pisa, 56126, Pisa, Italy., Souza VC; Hospital São Rafael Oncologia D'Or, Salvador, BA, Brazil.; Latin American Cooperative Oncology Group - LACOG, Porto Alegre, Brazil., Pichler R; Department of Urology, Medical University of Innsbruck, Anichstrasse 35, 6020, Innsbruck, Austria., De Giorgi U; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Gandur N; Latin American Cooperative Oncology Group - LACOG, Porto Alegre, Brazil.; Hospital Angel Roffo, Buenos Aires, CABA, Argentina., Lam ET; University of Colorado Anschutz Medical Campus, Aurora, CO, USA., Gilbert D; University of Colorado Anschutz Medical Campus, Aurora, CO, USA., Popovic L; Oncology Institute of Vojvodina, Faculty of Medicine, University Novi Sad, Novi Sad, Serbia., Grande E; Department of Medical Oncology, MD Anderson Cancer Center Madrid, Madrid, Spain., Mammone G; Department of Radiological, Oncological and Anatomo-Pathological Science, 'Sapienza' University of Rome, Viale Regina Elena 324, 00185, Rome, Italy., Berardi R; Department of Medical Oncology, Università Politecnica Delle Marche, AOU Ospedali Riuniti Delle Marche, Ancona, Italy., Crabb SJ; Southampton Experimental Cancer Medicine Centre, University of Southampton, Southampton, UK., Kemp R; Southampton Experimental Cancer Medicine Centre, University of Southampton, Southampton, UK., Molina-Cerrillo J; Department of Medical Oncology, Hospital Ramón y Cajal, Madrid, Spain., Freitas M; Latin American Cooperative Oncology Group - LACOG, Porto Alegre, Brazil.; Centro de Pesquisas Oncológicas - CEPON, Florianópolis, SC, Brazil., Luz M; Latin American Cooperative Oncology Group - LACOG, Porto Alegre, Brazil.; Hospital Erasto Gaertner, Curitiba, PR, Brazil., Iacovelli R; Oncologia Medica, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy., Calabrò F; Department of Oncology, San Camillo Forlanini Hospital, Rome, Italy., Tural D; Department of Medical Oncology, Bakirköy Dr. SadiKonuk Training and Research Hospital, Tevfik Saglam St. No: 11, Zuhuratbaba District, Bakirkoy, Istanbul, Turkey., Atzori F; Unità di Oncologia Medica, Azienda Ospedaliero Universitaria di Cagliari, Cagliari, Italy., Küronya Z; Department of Genitourinary Medical Oncology and Clinical Pharmacology, National Institute of Oncology, Budapest, Hungary., Chiari R; UOC Oncologia, Azienda Ospedaliera Ospedali Riuniti Marche Nord, Fano, Italy., Campos S; Latin American Cooperative Oncology Group - LACOG, Porto Alegre, Brazil.; Centro Oncologico Estatal 'Dr José Luis Barrera Franco' del ISSEMYM, Toluca de Lerdo, Mexico., Caffo O; Medical Oncology Unit, Santa Chiara Hospital, Trento, Italy., Fay AP; Latin American Cooperative Oncology Group - LACOG, Porto Alegre, Brazil.; Pontificia Universidade Católica do Rio Grande do Sul - PUCRS, Porto Alegre, RS, Brazil., Kucharz J; Department of Uro-Oncology, Maria Sklodowska-Curie National Research Institute of Oncology Warsaw, Warsaw, Poland., Zucali PA; Department of Oncology, IRCCS Humanitas Research Hospital, Rozzano - Milan, Italy.; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy., Rinck JA; Latin American Cooperative Oncology Group - LACOG, Porto Alegre, Brazil.; Hospital AC Camargo, São Paulo, SP, Brazil., Zeppellini A; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy., Bastos DA; Latin American Cooperative Oncology Group - LACOG, Porto Alegre, Brazil.; Department of Oncology, Hospital Sírio-Libanês, São Paulo, SP, Brazil., Aurilio G; Division of Cancer Prevention and Genetics, IEO European Institute of Oncology IRCCS, Milan, Italy., Mota A; Latin American Cooperative Oncology Group - LACOG, Porto Alegre, Brazil.; Clínica AMO, Salvador, BA, Brazil., Trindade K; Latin American Cooperative Oncology Group - LACOG, Porto Alegre, Brazil.; Oncologia D'Or, Fortaleza, CE, Brazil., Ortega C; ASLCN2 Alba-Bra, Ospedale Michele E Pietro Ferrero, Verduno, CN, Italy., Sade JP; Instituto Alexander Fleming, Buenos Aires, CABA, Argentina., Rizzo M; Division of Medical Oncology, A.O.U. Consorziale Policlinico Di Bari, Piazza G. Cesare 11, 70124, Bari, Italy., Fiala O; Department of Oncology and Radiotherapeutics, Faculty of Medicine, University Hospital in Pilsen, Charles University, Pilsen, Czech Republic., Vau N; Urologic Oncology, Champalimaud Clinical Center, 1400-038, Lisbon, Portugal., Giannatempo P; Dipartimento di Oncologia Medica, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy., Barillas A; Latin American Cooperative Oncology Group - LACOG, Porto Alegre, Brazil.; Clinicas Medicas Especializadas NUCARE, Guatemala City, Guatemala., Monteiro FSM; Latin American Cooperative Oncology Group - LACOG, Porto Alegre, Brazil.; Hospital Sirio-Libanês, Brasília, DF, Brazil., Dauster B; Latin American Cooperative Oncology Group - LACOG, Porto Alegre, Brazil.; Hospital Sao Rafael, Salvador, BA, Brazil., Mennitto A; Department of Medical Oncology, 'Maggiore Della Carità' University Hospital, 28100, Novara, Italy., Nogueira L; Latin American Cooperative Oncology Group - LACOG, Porto Alegre, Brazil.; Universidade Federal de Minas Gerais - UFMG, Belo Horizonte, MG, Brazil., de Carvalho Fernandes R; Latin American Cooperative Oncology Group - LACOG, Porto Alegre, Brazil.; Hospital Santa Casa de Sao Paulo, São Paulo, SP, Brazil., Seront E; Department of Medical Oncology, Centre Hospitalier de Jolimont, Haine Saint Paul, Belgium., Aceituno LG; Latin American Cooperative Oncology Group - LACOG, Porto Alegre, Brazil.; Clinica Medica Especializada en Oncologia Medica, Guatemala City, Guatemala., Grillone F; UO Oncologia Azienda Ospedaliera Universitaria Renato Dulbecco PO Pugliese Ciaccio Catanzaro, Catanzaro, Italy., Cutuli HJ; Latin American Cooperative Oncology Group - LACOG, Porto Alegre, Brazil.; Hospital Sirio Libanes, Buenos Aires, CABA, Argentina., Fernandez M; Latin American Cooperative Oncology Group - LACOG, Porto Alegre, Brazil.; Fundacion Centro Oncologico de Integracion Regional - COIR, Mendoza, Argentina., Bassanelli M; Medical Oncology 1-IRCCS Regina Elena National Cancer Institute, Rome, Italy., Kopp RM; Clinical Oncology, Sociedad de Oncología y Hematología del Cesar, Valledupar, Colombia., Roviello G; Department of Health Sciences, Section of Clinical Pharmacology and Oncology, University of Florence, Viale Pieraccini 6, 50139, Florence, Italy., Abahssain H; Medicine and Pharmacy Faculty, National Institute of Oncology, Medical Oncology Unit, Mohamed V University, Rabat, Morocco., Procopio G; Dipartimento di Oncologia Medica, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.; Oncologia Medica, Ospedale Maggiore di Cremona, Cremona, Italy., Milella M; Section of Oncology, Department of Medicine, University of Verona School of Medicine and Verona University Hospital Trust, Verona, Italy., Kopecky J; Department of Clinical Oncology and Radiotherapy, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic., Martignetti A; Dipartimento Oncologico USL Sud-Est Toscana-Area Senese, Località Campostaggia S.N.C, 53036, Poggibonsi, Italy., Messina C; Oncology Unit, A.R.N.A.S. Civico, Palermo, Italy., Caitano M; Latin American Cooperative Oncology Group - LACOG, Porto Alegre, Brazil.; Hospital do Câncer Porto Dias - Rede Mater Dei de Saúde, Belém, PA, Brazil., Inman E; Latin American Cooperative Oncology Group - LACOG, Porto Alegre, Brazil.; ONCOR Life Medical Center, Saltillo, Mexico., Kanesvaran R; National Cancer Centre Singapore, Singapore, Singapore., Herchhorn D; Latin American Cooperative Oncology Group - LACOG, Porto Alegre, Brazil.; Instituto D'Or de Ensino e Pesquisa, Rio de Janeiro, RJ, Brazil., Santini D; Department of Radiological, Oncological and Pathological Sciences, Policlinico Umberto I, University of Rome, SapienzaRome, Italy., Bamias A; 2nd Propaedeutic Department of Internal Medicine, ATTIKON University Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece., Bisonni R; UOC Oncologia Medica, Ospedale A. Murri, Fermo, Italy., Mosca A; Oncology, Candiolo Cancer Institute, IRCCS-FPO, 10060, Turin, Italy., Morelli F; Medical Oncology Unit, Gemelli Molise Hospital, Università Cattolica del Sacro Cuore, Campobasso, Italy., Maluf F; Latin American Cooperative Oncology Group - LACOG, Porto Alegre, Brazil.; Hospital Beneficencia Portuguesa de São Paulo, São Paulo, SP, Brazil., Soares A; Latin American Cooperative Oncology Group - LACOG, Porto Alegre, Brazil.; Hospital Israelita Albert Einstein, São Paulo, SP, Brazil., Nunes F; Latin American Cooperative Oncology Group - LACOG, Porto Alegre, Brazil.; Clinica de Oncologia - Clion, Salvador, BA, Brazil., Pinto A; Medical Oncology Department, La Paz University Hospital, Madrid, Spain., Zgura A; Department of Oncology-Radiotherapy, Prof. Dr. Alexandru Trestioreanu Institute of Oncology, Carol Davila; University of Medicine and Pharmacy, Bucharest, Romania., Incorvaia L; Department of Precision Medicine in Medical, Surgical and Critical Care (Me.Pre.C.C.), Section of Medical Oncology, University of Palermo, Via del Vespro 129, 90127, Palermo, Italy., Ansari J; Medical Oncology, Tawam Hospital, Al Ain, United Arab Emirates., Zabalza IO; Department of Medical Oncology, MD Anderson Cancer Center Madrid, Madrid, Spain., Landmesser J; Klinik für Urologie, Ratzeburger Allee 160, 23538, Lübeck, Germany., Rizzo A; Struttura Semplice Dipartimentale di Oncologia Medica per la Presa in Carico Globale del Paziente Oncologico 'Don Tonino Bello', I.R.C.C.S. Istituto Tumori 'Giovanni Paolo II', Viale Orazio Flacco 65, 70124, Bari, Italy., Mollica V; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy., Marchetti A; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy., Rosellini M; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy., Sorgentoni G; Oncology Unit, Macerata Hospital, via Santa Lucia 2, 62100, Macerata, Italy., Battelli N; Oncology Unit, Macerata Hospital, via Santa Lucia 2, 62100, Macerata, Italy., Buti S; Medical Oncology Unit, Department of Medicine and Surgery, University Hospital of Parma, University of Parma, Parma, Italy., Porta C; Chair of Oncology, Interdisciplinary Department of Medicine, University of Bari 'Aldo Moro', Bari, Italy., Bellmunt J; Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
Source: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2024 Apr 18; Vol. 73 (6), pp. 106. Date of Electronic Publication: 2024 Apr 18.
Publication Type: Journal Article; Observational Study
Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1432-0851
DOI:10.1007/s00262-024-03682-w